See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Top Rated

Related Research Videos on Diabetes Health TV

Medtronic Diabetes

Courtney Parkin

Medtronic Diabetes

Continuous Glucose Monitoring with DEXCOM's

Deb Ruppert

Continuous Glucose Monitoring with DEXCOM's "The Seven"

New Small Molecule Drugs for Type 2 - Human Trials Underway

Christoph Westphal, MD, Ph.D

New Small Molecule Drugs for Type 2 - Human Trials Underway

Beta Cells Archives

Diabetes and Beta Cells

Page 4
Relieving Stress on Insulin-Producing Cells May Prevent Diabetes

BOSTON, Mass. - Dec. 23, 2009 - Cells in your body are constantly churning out poisonous forms of oxygen (oxidants) and mopping them up with a countervailing force of proteins and chemicals (anti-oxidants). This balancing act of oxidative stress is particularly likely to go haywire in beta cells, the insulin-producing cells that malfunction and then start to die off in type 2 diabetes.

Comments 2 comments - Dec 29, 2009 - * * * * *

Cancer Drug May Slow Body's Rejection of Beta Cells in Type 1

Rituxamab, a drug that treats lymphoma and rheumatoid arthritis, may soon be used to help combat the destruction of pancreatic beta cells in newly diagnosed cases of type 1 diabetes. Researchers at Indiana University have found that the drug, originally developed and sold by Genentech as Rituxan, temporarily slows or stops the destruction of the 10 or 20 percent of beta cells that type 1s typically have remaining when they are first diagnosed.

Comments 0 comments - Dec 21, 2009 - * * * * *

JDRF Announces Diabetes Research Program with Johnson & Johnson

NEW YORK, Dec. 17, 2009 - The Juvenile Diabetes Research Foundation, a leader in setting the agenda for diabetes research worldwide, said today that it will begin working with The Johnson & Johnson Corporate Office of Science and Technology, and its affiliates, to speed the development of drug targets and pathways to promote the survival and function of insulin-producing cells in people who have diabetes.  The program will look to fund research at academic centers around the world that could eventually lead to novel drug targets and industry collaborations for the treatment of type 1 diabetes.

Comments 2 comments - Dec 19, 2009 - * * * * *

Airman Injured in Afghanistan Receives Unprecedented Islet Cell Transplant

WASHINGTON, Dec. 15 /PRNewswire-USNewswire/ -- A 21-year old Airman severely wounded in Afghanistan is recovering at Walter Reed Army Medical Center after several surgeries and an unprecedented transplant.

Comments 2 comments - Dec 17, 2009 - * * * * *

Promising Pancreate Creates New Islets

One thing that really frustrates people with diabetes mellitus is the biopharma industry's focus on treatments rather than cures. A cure is what the diabetes community wants, not another band-aid. So the existence of a biopharma company that calls itself "CureDM" is promising, and its first product, Pancreate, seems to be on its way to fulfilling that promise.

Comments 21 comments - Sep 28, 2009 - * * * * *

Diabetes in a Dish: Steps Toward a Cure

By reprogramming skin cells from people with type 1 diabetes, scientists have produced beta cells that secrete insulin in response to changes in glucose levels. Dr. Douglas Melton and his colleagues at the Harvard Stem Cell Institute started by using the skin cells to generate induced pluripotent stem (iPS) cells. Once they had iPS cells, the researchers manipulated them into developing into pancreatic islet (beta) cells.

Comments 4 comments - Sep 19, 2009 - * * * * *

To be or not to be... a pancreatic beta cell

Our genes are like a recipe for a human. It's a very complicated recipe, determining how much of this protein and how much of that enzyme need to be added into the mix in order for us to function properly, but our genes are pretty good at getting it right. Although we are still learning how the recipe works, what ingredients (gene products) are involved, and when are they are produced, our knowledge is growing fast.  

Comments 2 comments - Aug 28, 2009 - * * * * *

Scientists Find That a Single Gene Can Convert Pancreatic Alpha Cells Into Betas in Lab Mice

There's a gene whose name you should remember because it could mark a crucial point in the war on type 1 diabetes.

Comments 3 comments - Aug 13, 2009 - * * * * *

MRI May Join the Diagnostic Toolkit for Diabetes

A study from Massachusetts General Hospital and Harvard Medical School in Boston says that magnetic resonance imaging could become a useful tool for diagnosing diabetes and helping doctors determine the proper course of treatment.

Comments 3 comments - Aug 8, 2009 - * * * * *

Protein Build-Up in Baboons' Pancreases Could Hold a Key to the Onset of Type 2 Diabetes

A protein that builds up in the pancreases of baboons and leads to the suppression of insulin-producing beta cells, may provide one of the most significant indicators yet for predicting the onset of type 2 diabetes.

Comments 1 comment - Jul 28, 2009 - * * * * *

Next Page » « Previous Page
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.